Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Proteasome inhibitor PS-519 demonstrates cardioprotective activity in preclinical model

April 26, 1999

Moxonidine metabolite synthesized by Lilly and assessed in SHR

April 23, 1999

New beta blocker facilitates beating-heart surgery

April 23, 1999

Progen's heparanase inhibitor prevents restenosis in experimental model

April 22, 1999

AVI confirms that classic approaches valid for testing antisense compound

April 22, 1999

Angiotensin immunization as an immunotherapeutic approach to hypertension

April 21, 1999

Gene therapy for congestive heart failure studied in mice

April 21, 1999

Avant Immunotherapeutics' CETP vaccine is effective in rabbit models of atherosclerosis

April 20, 1999

News from FASEB: ETA antagonist with potential in the treatment of pulmonary hypertension

April 19, 1999

Bay-y-5959 is not associated with proarrhythmic activity in dogs with CHF

April 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...